This month, we had the honor of welcoming Lehendakari Imanol Pradales and key members of his government team to our facilities; Mikel Jauregi, Minister of Industry, Energy Transition and Sustainability; Juan Ignacio Pérez Iglesias, Minister of Science, University, and Innovation; and Jaione Ganzarain, Deputy Minister of Technology, Innovation, and Digital Transformation.
During their visit, we had the opportunity to share Viralgen’s mission of bringing advanced treatments to those who need them most, to showcase the science that takes place in our laboratories and give insights on AAVs (Adeno-Associated Virus vectors) manufacturing process, critical to gene therapies.
We are deeply grateful to have hosted these important visitors/ stakeholders and appreciate the continuous support critical for developing innovative therapies in the Basque country. This visit strengthens our commitment to health and innovation, as we work together to advance progress in the field of gene therapies.
News
September 26, 2024
Visit of Lehendakari Imanol Pradales and his team to Viralgen facilities: A step forward in advancing gene therapies
Explore more
Resources
Webinar: Exploring key regulatory considerations to ensure patient safety in the gene therapy space
In July, a panel of expert speakers—Christine Lebec (Sensorion), Leigh Shaw (SpliceBio), Nathalie Clement (Siren Biotechnology), and María Orío (Viralgen)—came together to explore the evolving regulatory landscape in the cell and gene therapy (CGT)...
READ MORE
July 09, 2025

Resources
Streamlining Advanced Therapy Medicinal Product Manufacturing: A Platform Approach for Accelerating Gene Therapy Commercialization
Viralgen is streamlining gene therapy manufacturing with a platform approach that accelerates timelines and reduces complexity. By leveraging process knowledge across multiple AAV serotypes, we enable faster production while ensuring quality and...
READ MORE
May 15, 2025

Resources
Leveraging Historical Data and Percentile-based Modeling for Improved AAV Production Scaling
At Viralgen, we’re tackling one of the biggest challenges in gene therapy manufacturing: scaling AAV production from research to GMP. By analyzing historical data and applying percentile-based modeling, our team developed a predictive approach that...
READ MORE
May 15, 2025